Itamar Medical Ltd. (ITMR)
| Market Cap | 503.63M |
| Revenue (ttm) | 50.88M |
| Net Income (ttm) | -21.19M |
| Shares Out | 16.42M |
| EPS (ttm) | -1.47 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 17,572 |
| Open | 30.70 |
| Previous Close | 30.65 |
| Day's Range | 30.66 - 30.74 |
| 52-Week Range | 16.36 - 30.80 |
| Beta | 0.54 |
| Analysts | Strong Buy |
| Price Target | 28.34 (-7.6%) |
| Earnings Date | Nov 16, 2021 |
About ITMR
Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses e...
Financial Performance
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for Itamar Medical stock is "Strong Buy." The 12-month stock price forecast is 28.34, which is a decrease of -7.59% from the latest price.
News
Itamar Medical Ltd. Sponsored ADR (ITMR) Reports Q3 Loss, Lags Revenue Estimates
Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of -63.33% and 0.98%, respectively, for the quarter ended September 2021.
Itamar Medical Reports Third Quarter 2021 Financial Results
- Revenues Increase d 23 % Year-over-Year to $ 13.6 Million -
Analysts Estimate Itamar Medical Ltd. Sponsored ADR (ITMR) to Report a Decline in Earnings: What to Look Out for
Itamar Medical Ltd. Sponsored ADR (ITMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of It...
New York, New York--(Newsfile Corp. - September 13, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased Itamar Medical Ltd. (NASDAQ: ITMR) ...
ITMR Stock: The $538M Reason Why Itamar Medical Is Soaring 45% on Monday
ZOLL Medical isn't sleeping on the chance to acquire sleep apnea pioneer Itamar. Shares of ITMR stock are reacting well to the news.
Why Itamar Medical Stock Is Skyrocketing Today
Zoll Medical plans to acquire the small producer of medical devices.
Itamar Medical Goes Private In $538M Deal: All You Need To Know
ZOLL Medical Corporation, an Asahi Kasei company, has agreed to acquire Itamar Medical Ltd (NASDAQ: ITMR) for a total value of approximately $538 million. Itamar Medical focuses on the development and c...
ZOLL Medical Corporation Signs Definitive Agreement to Acquire Itamar Medical
CHELMSFORD, Mass. & CAESAREA, Israel--(BUSINESS WIRE)--ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and Itamar™ Medical Ltd. (Nasda...
Itamar Medical Appoints Marga Ortigas-Wedekind to its Board of Directors
CAESAREA, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management ...
Itamar Medical Ltd. Sponsored ADR (ITMR) Reports Q2 Loss, Tops Revenue Estimates
Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of 3.33% and 3.97%, respectively, for the quarter ended June 2021.
Itamar Medical: Q2 Earnings Insights
Shares of Itamar Medical (NASDAQ:ITMR) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share decreased 17.65% year over year to ($0.20), which beat the estimate...
Itamar Medical Reports Second Quarter 2021 Financial Results
- Revenues Increased 41% Year-over-Year to $12.6 Million -
Earnings Preview: Itamar Medical Ltd. Sponsored ADR (ITMR) Q2 Earnings Expected to Decline
Itamar Medical Ltd. Sponsored ADR (ITMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
Itamar Medical to Report Second Quarter Financial Results and Host Conference Call on Tuesday, August 10, 2021
CAESAREA, Israel, July 28, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management ...
Itamar Medical to Present at the Ladenburg Thalmann Annual Healthcare Conference on Wednesday, July 14, 2021
CAESAREA, Israel, June 30, 2021 (GLOBE NEWSWIRE) -- ItamarTM Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea managemen...
Itamar Medical Launches Enhancements to WatchPAT™ Product Line at SLEEP 2021
Enables Patient Smartphone App to Collect Subjective Data at Time of Test
Itamar Medical Appoints Brad Fluegel to its Board of Directors
CAESAREA, Israel, May 24, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management i...
Itamar Medical Ltd. Sponsored ADR (ITMR) Moves 6.5% Higher: Will This Strength Last?
Itamar Medical Ltd. Sponsored ADR (ITMR) saw its shares surge in the last session with trading volume being higher than average.
Itamar Medical: Q1 Earnings Insights
Shares of Itamar Medical (NASDAQ:ITMR) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share were down 81.82% over the past year to ($0.20), which missed the es...
Itamar Medical Reports First Quarter 2021 Results
– First Quarter 2021 Revenues Increase 43% to $12.0 Million –
Itamar Medical's Earnings Outlook
On Wednesday, May 19, Itamar Medical (NASDAQ:ITMR) will release its latest earnings report. Here is Benzinga's outlook for the company.
Itamar Medical's WatchPAT® Technology Featured in Ladenburg Thalmann Healthcare Symposia Call Series
CAESAREA, Israel, May 10, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management i...
Itamar Medical to Report First Quarter Financial Results and Host Conference Call on Wednesday, May 19, 2021
CAESAREA, Israel, May 05, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management i...
Itamar Medical Provides Highlights of Recent Survey in Sleep Test Market
Significant Majority Expect Home Sleep Apnea Test Usage to Expand and in-lab Usage to Decline
Itamar Medical Ltd. Sponsored ADR (ITMR) Reports Q4 Loss, Tops Revenue Estimates
Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of -7.14% and 0.57%, respectively, for the quarter ended December 2020.